In a recent transaction, Howard G. Welgus, a director at Arcutis Biotherapeutics Inc . (NASDAQ:ARQT), sold 10,000 shares of the company's common stock. The shares were sold at a weighted average price ...
Officer and Director at Nexalin Technology , Inc. (NASDAQ:NXL), recently acquired 1,000 shares of the company's common stock. The purchase, executed on February 4, 2025, was made at a price of $2.98 ...
Issuance of common stock refers to the process by which a company sells its shares to investors to raise capital. Common stock represents ownership in the company, granting shareholders voting ...
Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...
Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help ...